Merck inks two pacts for investigational HIV drug – Marketwatch

Merck & Co. (NYSE:MRK) has signed two licensing agreements for investigational HIV drug candidates and also unveiled plans for a study to investigate an internally developed HIV drug candidate. The drug company signed a deal with Chimerix Inc …